tim.hodson
Tue, 10/21/2025 – 10:55
Oct. 21, 2025 — GT Medical Technologies has announced the interim results from its ROADS clinical trial (Randomized Controlled Trial of Resection [Surgery] and GammaTile versus Standard of Care) in patients with operable, newly diagnosed brain metastases.1
The trial, which completed randomization of 230 patients over 30 leading cancer centers in the United States in August 2025, evaluated whether implanting GammaTile — a form of brain tumor radiat…